A first-of-its-kind, federally funded clinical trial has shown it’s possible to identify breast cancer survivors who are at higher risk of their cancer coming back due to the presence of dormant cancer cells and to effectively treat these cells with repurposed, existing drugs. The research, led by scientists from the Abramson Cancer Center of the University of Pennsylvania and Penn’s Perelman School of Medicine was published today in Nature Medicine.
While breast cancer survival continues to…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply